Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness

Antipsychotic polypharmacy: never say never, but never say always

(2012) Stephen M. Stahl   ACTA PSYCHIATRICA SCANDINAVICA

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

(2012) Oliver D. Howes et al.   BRITISH JOURNAL OF PSYCHIATRY

Augmenting Clozapine With Sertindole

(2012) Jimmi Nielsen et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009

(2012) Juan A. Gallego et al.   SCHIZOPHRENIA RESEARCH

Augmentation of clozapine with a second antipsychotic - a meta-analysis

(2011) D. M. Taylor et al.   ACTA PSYCHIATRICA SCANDINAVICA

Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy

(2011) Susan M. Essock et al.   AMERICAN JOURNAL OF PSYCHIATRY

Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study

(2011) Fuminari Misawa et al.   BMC Psychiatry

A cross-sectional study of prescribing patterns in chronic psychiatric patients living in sheltered housing facilities

(2011) S.G. Schorr et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy

(2011) Joseph I Friedman et al.   NEUROPSYCHOPHARMACOLOGY

Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

(2011) Monica Hazra et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study

(2011) Maria Rosaria A. Muscatello et al.   SCHIZOPHRENIA RESEARCH

Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behavior

(2011) Christoph U. Correll et al.   SCHIZOPHRENIA RESEARCH

Treatment with antipsychotics and the risk of diabetes in clinical practice

(2010) Lars Vedel Kessing et al.   BRITISH JOURNAL OF PSYCHIATRY

Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial

(2010) W. Wolfgang Fleischhacker et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Antipsychotic Polypharmacy in Outpatients at Birch Hill Hospital: Incidence and Adherence to Guidelines

(2010) Nadezda Ranceva et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine

(2010) Elaine Weiner et al.   NEUROPSYCHOPHARMACOLOGY

Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia

(2010) Dimitrios Kontis et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Augmentation of clozapine with a second antipsychotic - a meta-analysis of randomized, placebo-controlled studies

(2009) D. M. Taylor et al.   ACTA PSYCHIATRICA SCANDINAVICA

Benefits and Risks of Antipsychotic Polypharmacy

(2009) Constantin Tranulis et al.   DRUG SAFETY

Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia

(2009) Jae Seung Chang et al.   JOURNAL OF CLINICAL PSYCHIATRY

Implementation of a Schizophrenia Practice Guideline

(2009) Stefan Weinmann et al.   JOURNAL OF CLINICAL PSYCHIATRY

Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder

(2009) D. Élie et al.   JOURNAL OF PSYCHOPHARMACOLOGY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Influence of antipsychotics on mortality in schizophrenia: Systematic review

(2009) Stefan Weinmann et al.   SCHIZOPHRENIA RESEARCH

Cost of antipsychotic polypharmacy in the treatment of schizophrenia

(2008) Baojin Zhu et al.   BMC Psychiatry

Weight change on aripiprazole-clozapine combination in schizophrenic patients with weight gain and suboptimal response on clozapine: 16-week double-blind study

(2008) W.W. Fleischhacker et al.   EUROPEAN PSYCHIATRY

The “3T’s” Road Map to Transform US Health Care

(2008) Denise Dougherty et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Amisulpride Augmentation in Patients with Schizophrenia Partially Responsive or Unresponsive to Clozapine. A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) H.-J. Assion et al.   PHARMACOPSYCHIATRY

Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

(2008) C. U. Correll et al.   SCHIZOPHRENIA BULLETIN

Does the Addition of a Second Antipsychotic Drug Improve Clozapine Treatment?

(2008) C. Barbui et al.   SCHIZOPHRENIA BULLETIN

Antipsychotic polypharmacy does not increase the risk for side effects

(2007) Soma Ganesan et al.   SCHIZOPHRENIA RESEARCH